SQUAWK/NEWS
Menu
Live News EQUITY L impact

GSK: Calm-1 Met Primary Endpoint With Camlipixant

No Stat Significance For Calm-2 In Same Primary Endpoint

No Stat Significance For Calm-2 In Same Primary Endpoint